Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional

Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

ClinicalTrials.gov ID: NCT03887520

Public ClinicalTrials.gov record NCT03887520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 12:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-center Cross-sectional Epidemiological Study to Characterize the Prevalence and Distribution of Lipoprotein(a) Levels Among Patients With Established Cardiovascular Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).

Study identification

NCT ID
NCT03887520
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
49,001 participants

Conditions and interventions

Interventions

Diagnostic Test

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 27, 2018 (Actual)
Primary completion
Jul 30, 2021 (Actual)
Completion
Jul 30, 2021 (Actual)
Last update posted
Jan 28, 2022

2018 – 2021

United States locations

U.S. sites
180
U.S. states
38
U.S. cities
153
Facility City State ZIP Site status
Novartis Investigative Site Andalusia Alabama 36420 —
Novartis Investigative Site Birmingham Alabama 35243 —
Novartis Investigative Site Huntsville Alabama 35801 —
Novartis Investigative Site Mobile Alabama 36608 —
Novartis Investigative Site Cottonwood Arizona 86326 —
Novartis Investigative Site Mesa Arizona 85206 —
Novartis Investigative Site Surprise Arizona 85374 —
Novartis Investigative Site Tucson Arizona 85745 —
Novartis Investigative Site Little Rock Arkansas 72204 —
Novartis Investigative Site Beverly Hills California 90211 —
Novartis Investigative Site Concord California 94520 —
Novartis Investigative Site Covina California 91723 —
Novartis Investigative Site Fresno California 93720 —
Novartis Investigative Site Huntington Beach California 92648 —
Novartis Investigative Site Long Beach California 90806 —
Novartis Investigative Site Los Angeles California 90033 —
Novartis Investigative Site Los Angeles California 90073 —
Novartis Investigative Site Northridge California 91325 —
Novartis Investigative Site Orange California 92868 —
Novartis Investigative Site Orangevale California 95662 —
Novartis Investigative Site San Diego California 92103 —
Novartis Investigative Site San Francisco California 94143 —
Novartis Investigative Site Santa Ana California 92704 —
Novartis Investigative Site Stanford California 94305 —
Novartis Investigative Site Stockton California 95204 —
Novartis Investigative Site Torrance California 90502 —
Novartis Investigative Site West Hills California 91307 —
Novartis Investigative Site Aurora Colorado 80045 —
Novartis Investigative Site Bridgeport Connecticut 06610 —
Novartis Investigative Site Hartford Connecticut 06102-5037 —
Novartis Investigative Site Waterbury Connecticut 06708 —
Novartis Investigative Site Boca Raton Florida 33434 —
Novartis Investigative Site Bradenton Florida 34209 —
Novartis Investigative Site Brandon Florida 33511 —
Novartis Investigative Site Hollywood Florida 33312 —
Novartis Investigative Site Jacksonville Florida 32205 —
Novartis Investigative Site Jacksonville Florida 32216 —
Novartis Investigative Site Jacksonville Florida 32223 —
Novartis Investigative Site Miami Florida 33133 —
Novartis Investigative Site Miami Florida 33176 —
Novartis Investigative Site Naples Florida 34102 —
Novartis Investigative Site Port Charlotte Florida 33952 —
Novartis Investigative Site Port Orange Florida 32127 —
Novartis Investigative Site Saint Augustine Florida 32086 —
Novartis Investigative Site Tampa Florida 33612 —
Novartis Investigative Site Wellington Florida 33449 —
Novartis Investigative Site Atlanta Georgia 30084 —
Novartis Investigative Site Atlanta Georgia 30309 —
Novartis Investigative Site Atlanta Georgia 30322 —
Novartis Investigative Site Dunwoody Georgia 30338 —
Novartis Investigative Site Thomasville Georgia 31792 —
Novartis Investigative Site Chicago Illinois 60612 —
Novartis Investigative Site Lombard Illinois 60148 —
Novartis Investigative Site Park Ridge Illinois 60068 —
Novartis Investigative Site Skokie Illinois 60077 —
Novartis Investigative Site Indianapolis Indiana 46202 4800 —
Novartis Investigative Site Indianapolis Indiana 46260 —
Novartis Investigative Site Iowa City Iowa 52242 —
Novartis Investigative Site Kansas City Kansas 66160 —
Novartis Investigative Site Topeka Kansas 66606 —
Novartis Investigative Site Louisville Kentucky 40213 —
Novartis Investigative Site Alexandria Louisiana 71301 —
Novartis Investigative Site Baton Rouge Louisiana 70808 —
Novartis Investigative Site Covington Louisiana 70433 —
Novartis Investigative Site Hammond Louisiana 70403 —
Novartis Investigative Site Houma Louisiana 70360 —
Novartis Investigative Site Lafayette Louisiana 70501 —
Novartis Investigative Site Metairie Louisiana 70006 —
Novartis Investigative Site New Orleans Louisiana 70112 —
Novartis Investigative Site New Orleans Louisiana 70115 —
Novartis Investigative Site Opelousas Louisiana 70570 —
Novartis Investigative Site Shreveport Louisiana 71101 —
Novartis Investigative Site Slidell Louisiana 70458 —
Novartis Investigative Site Zachary Louisiana 70791 —
Novartis Investigative Site Scarborough Maine 04074 —
Novartis Investigative Site Baltimore Maryland 21201 —
Novartis Investigative Site Baltimore Maryland 21209 —
Novartis Investigative Site Baltimore Maryland 21287 —
Novartis Investigative Site Columbia Maryland 21044 —
Novartis Investigative Site Ft. Washington Maryland 20744 —
Novartis Investigative Site Rockville Maryland 20850 —
Novartis Investigative Site Boston Massachusetts 02114-2696 —
Novartis Investigative Site Boston Massachusetts 02115 —
Novartis Investigative Site Bingham Farms Michigan 48025 —
Novartis Investigative Site Detroit Michigan 48201 —
Novartis Investigative Site Detroit Michigan 48202 —
Novartis Investigative Site Flint Michigan 48504 —
Novartis Investigative Site Grand Blanc Michigan 48439 —
Novartis Investigative Site Kalamazoo Michigan 49008 —
Novartis Investigative Site Midland Michigan 48640 —
Novartis Investigative Site Petoskey Michigan 49770 —
Novartis Investigative Site Saginaw Michigan 48601 —
Novartis Investigative Site Wyoming Michigan 49519 —
Novartis Investigative Site Minneapolis Minnesota 55407 —
Novartis Investigative Site Minneapolis Minnesota 55455 —
Novartis Investigative Site Saint Paul Minnesota 55102 —
Novartis Investigative Site Belzoni Mississippi 39038 —
Novartis Investigative Site Jackson Mississippi 39209 —
Novartis Investigative Site Southaven Mississippi 38671 —
Novartis Investigative Site Yazoo City Mississippi 39194 —
Novartis Investigative Site City of Saint Peters Missouri 63303 —
Novartis Investigative Site St Louis Missouri 63110 —
Novartis Investigative Site St Louis Missouri 63128 —
Novartis Investigative Site St Louis Missouri 63141 —
Novartis Investigative Site Lincoln Nebraska 68526 —
Novartis Investigative Site Omaha Nebraska 68114 —
Novartis Investigative Site Omaha Nebraska 68134 —
Novartis Investigative Site Lebanon New Hampshire 03756 —
Novartis Investigative Site Nashua New Hampshire 03060 —
Novartis Investigative Site Ridgewood New Jersey 07450 —
Novartis Investigative Site Summit New Jersey 07901 —
Novartis Investigative Site Albany New York 12206 —
Novartis Investigative Site Binghamton New York 13901 —
Novartis Investigative Site Endwell New York 13760 —
Novartis Investigative Site Manhasset New York 11030 —
Novartis Investigative Site New York New York 10016 —
Novartis Investigative Site New York New York 10021 —
Novartis Investigative Site New York New York 10029 —
Novartis Investigative Site New York New York 43210 —
Novartis Investigative Site North Massapequa New York 11758 —
Novartis Investigative Site Riverhead New York 11901 —
Novartis Investigative Site Rochester New York 14642 —
Novartis Investigative Site The Bronx New York 10467 2490 —
Novartis Investigative Site Charlotte North Carolina 28204 —
Novartis Investigative Site Greensboro North Carolina 27408 —
Novartis Investigative Site Morehead City North Carolina 28557 —
Novartis Investigative Site Raleigh North Carolina 27609 —
Novartis Investigative Site Sanford North Carolina 27330 —
Novartis Investigative Site Shelby North Carolina 28150 —
Novartis Investigative Site Winston-Salem North Carolina 27157 —
Novartis Investigative Site Akron Ohio 44309 —
Novartis Investigative Site Canton Ohio 44710 —
Novartis Investigative Site Cincinnati Ohio 45219 —
Novartis Investigative Site Cincinnati Ohio 45246 —
Novartis Investigative Site Cincinnati Ohio 45267 —
Novartis Investigative Site Cleveland Ohio 44195 —
Novartis Investigative Site Marion Ohio 43302 —
Novartis Investigative Site Portland Oregon 97239 —
Novartis Investigative Site Lancaster Pennsylvania 17603 —
Novartis Investigative Site Lansdale Pennsylvania 19446 —
Novartis Investigative Site Philadelphia Pennsylvania 19104 —
Novartis Investigative Site Pittsburgh Pennsylvania 15212 —
Novartis Investigative Site Yardley Pennsylvania 19067 —
Novartis Investigative Site Providence Rhode Island 02906 —
Novartis Investigative Site Fort Mill South Carolina 29707 —
Novartis Investigative Site Summerville South Carolina 29485 —
Novartis Investigative Site Rapid City South Dakota 57701 —
Novartis Investigative Site Germantown Tennessee 38138 —
Novartis Investigative Site Jackson Tennessee 38301 —
Novartis Investigative Site Knoxville Tennessee 37917 —
Novartis Investigative Site Nashville Tennessee 37203 —
Novartis Investigative Site Nashville Tennessee 37232 —
Novartis Investigative Site Beaumont Texas 77702 —
Novartis Investigative Site Dallas Texas 75226 —
Novartis Investigative Site Dallas Texas 75231 —
Novartis Investigative Site Dallas Texas 75235 —
Novartis Investigative Site Dallas Texas 75390 —
Novartis Investigative Site Houston Texas 77030 —
Novartis Investigative Site Livingston Texas 77351 —
Novartis Investigative Site Lufkin Texas 75904 —
Novartis Investigative Site Marshall Texas 75670 —
Novartis Investigative Site Plano Texas 75093 —
Novartis Investigative Site Sugar Land Texas 77479 —
Novartis Investigative Site Temple Texas 76508 —
Novartis Investigative Site Tomball Texas 77375 —
Novartis Investigative Site Bountiful Utah 84010 —
Novartis Investigative Site Layton Utah 84041 —
Novartis Investigative Site Murray Utah 84107 —
Novartis Investigative Site Salt Lake City Utah 84132 —
Novartis Investigative Site Danville Virginia 24541 —
Novartis Investigative Site Falls Church Virginia 22042 —
Novartis Investigative Site Manassas Virginia 20109 —
Novartis Investigative Site Norfolk Virginia 23510 —
Novartis Investigative Site Richmond Virginia 23219 —
Novartis Investigative Site Seattle Washington 98104 —
Novartis Investigative Site Seattle Washington 98122 —
Novartis Investigative Site Seattle Washington 98195 —
Novartis Investigative Site Tacoma Washington 98405 —
Novartis Investigative Site Madison Wisconsin 53705 —
Novartis Investigative Site Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 720 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03887520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2022 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03887520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →